234 related articles for article (PubMed ID: 17911190)
41. Increased platelet aggregation in diabetic patients with microangiopathy despite good glycemic control.
Kajita K; Ishizuka T; Miura A; Kanoh Y; Ishizawa M; Kimura M; Yasuda K
Platelets; 2001 Sep; 12(6):343-51. PubMed ID: 11672473
[TBL] [Abstract][Full Text] [Related]
42. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
43. Circulating P-, L- and E-selectins in pseudoxanthoma elasticum patients.
Götting C; Adam A; Szliska C; Kleesiek K
Clin Biochem; 2008 Apr; 41(6):368-74. PubMed ID: 18191640
[TBL] [Abstract][Full Text] [Related]
44. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
[TBL] [Abstract][Full Text] [Related]
45. Putative role of adhesion molecules in metabolic disorders.
Wagner OF; Jilma B
Horm Metab Res; 1997 Dec; 29(12):627-30. PubMed ID: 9497900
[TBL] [Abstract][Full Text] [Related]
46. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
[TBL] [Abstract][Full Text] [Related]
47. [Clinical significance of soluble selectins and matrix metalloproteinases-9 in patients after successful cardiopulmonary resuscitation].
Li PJ; Yang XH; Zhang LP; Cao W; Qin J; Yao W
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):137-41. PubMed ID: 15009958
[TBL] [Abstract][Full Text] [Related]
48. Increased soluble selectins as a reflection of activated platelets and endothelium in Legg-Calve-Perthes disease.
Ismayilov V; Aksoy DY; Sayinalp N; Haznedaroğlu IC; Aksoy MC
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e410-1. PubMed ID: 25000467
[TBL] [Abstract][Full Text] [Related]
49. Adhered platelet morphology in diabetes mellitus.
Kim SW; Ryu GH; Lee I; Koh JJ; Min BG; Lee HK
Diabete Metab; 1995 Feb; 21(1):50-3. PubMed ID: 7781844
[TBL] [Abstract][Full Text] [Related]
50. Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphism.
Panzer S; Rosales S; Gisslinger H; Jungbauer L; Kaider A; Knöbl P; Sillaber C; Pabinger I
Thromb Res; 2008; 121(4):573-9. PubMed ID: 17698171
[TBL] [Abstract][Full Text] [Related]
51. [Prostacyclin-like activity modifying plasma factors in diabetic microangiopathy].
Magyari M; Túri S; Csanálosi-Németh M
Fortschr Ophthalmol; 1990; 87(3):269-73. PubMed ID: 2115854
[TBL] [Abstract][Full Text] [Related]
52. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
Azadbakht L; Atabak S; Esmaillzadeh A
Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902
[TBL] [Abstract][Full Text] [Related]
53. Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behçet's syndrome.
Turkoz Y; Evereklioglu C; Ozkiriş A; Mistik S; Borlu M; Ozerol IH; Duygulu F; Ilhan O
Mediators Inflamm; 2005 Aug; 2005(4):237-41. PubMed ID: 16192675
[TBL] [Abstract][Full Text] [Related]
54. Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
Faur L; Motocu M; Moldovan C; Onaca M; Muţiu G
Rom J Morphol Embryol; 2005; 46(4):307-9. PubMed ID: 16688368
[TBL] [Abstract][Full Text] [Related]
55. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus.
Nagy B; Csongrádi E; Bhattoa HP; Balogh I; Blaskó G; Paragh G; Kappelmayer J; Káplár M
Thromb Haemost; 2007 Jul; 98(1):186-91. PubMed ID: 17598012
[TBL] [Abstract][Full Text] [Related]
56. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.
Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y
Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824
[TBL] [Abstract][Full Text] [Related]
57. Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal, obese and type 2 diabetic subjects.
Ferlito S; Gallina M
Minerva Endocrinol; 2000 Jun; 25(2):33-7. PubMed ID: 11189789
[TBL] [Abstract][Full Text] [Related]
58. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus.
Nomura S; Kanazawa S; Fukuhara S
J Hum Hypertens; 2002 Aug; 16(8):539-47. PubMed ID: 12149659
[TBL] [Abstract][Full Text] [Related]
59. Mean platelet volume and related factors in patients at different stages of diabetic nephropathy: a preliminary study.
Turgutalp K; Özhan O; Akbay E; Tombak A; Tiftik N; Ozcan T; Yilmaz S; Helvaci I; Kiykim A
Clin Appl Thromb Hemost; 2014 Mar; 20(2):190-5. PubMed ID: 22914809
[TBL] [Abstract][Full Text] [Related]
60. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease.
Serebruany V; Pokov I; Kuliczkowski W; Chesebro J; Badimon J
Thromb Haemost; 2008 Jul; 100(1):76-82. PubMed ID: 18612541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
